|
|||||
|
|
Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIV |
|
| Authors: | E Randall Lanier Roger G Ptak Bernhard M Lampert Laurie Keilholz Tracy Hartman Robert W Buckheit Jr Marie K Mankowski Mark C Osterling Merrick R Almond George R Painter |
| Institution: | Chimerix Inc., Durham, North Carolina,1. Southern Research Institute, Frederick, Maryland,2. ImQuest BioSciences, Frederick, Maryland3. |
| Abstract: | |
| Keywords: | |